- Udyam number
- UDYAM-GJ-22-0027771

About R.N. Laboratories Private Limited
Data last updated:
R.N. Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 04 December 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24200MH1998PTC117339. Its GSTIN is 27AAECS2969P2ZI (Maharashtra). The company holds 6 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.91 Cr. It was formerly known as Sky Chem Private Limited. It is led by directors including Vijay Nilkanth Koyande and Rohit Shamlal Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹135.13 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹49.33 Lakh (net margin 0.4%) and EBITDA of ₹12.62 Cr (EBITDA margin 9.3%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 3% over five years.
The company has about 242 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹152 Cr and satisfied charges of ₹38.5 Cr on record. Court records list 29 cases involving the company, including 20 filed by the company and 9 filed against it; 4 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in October 2018. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Atul Bioscience Limited with revenue of ₹136.8 Cr.
R.N. Laboratories Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0027771). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rnlaboratories.com.
Company details
Recognitions & Rankings of R.N. Laboratories
Contact details
R.N. Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is rnlaboratories.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA305 Vip Plaza Off Link Road Veera Desai Road Andheri, West, Mumbai, Maharashtra, India – 400053
- IndustryPharma, API Manufacturers
To see the full contact details of R.N. Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of R.N. Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of R.N. Laboratories Private Limited, buy the company report.
Financials of R.N. Laboratories Private Limited
FY 2025 filings availableR.N. Laboratories Private Limited reported revenue of ₹135.13 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 19% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.62 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹49.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of R.N. Laboratories Private Limited, buy the company report.
Board of directors of R.N. Laboratories Private Limited
R.N. Laboratories has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Nilkanth Koyande | Director | 13 Aug 2025 | 1 Years 3 Months | Current |
| Rohit Shamlal Garg Also directs: Garonit Pharmaceuticals Private Limited | Director | 04 Dec 1998 | 27 Years 11 Months | Current |
| Sanket Dhondiraj Sawant Also directs: Sanhit Risk & Growth LLP | Director | 30 Jul 2021 | 5 Years 3 Months | Current |
| Nitin Sham Lal Garg Also directs: Garonit Pharmaceuticals Private Limited, Neelam Garg Foundation | Director | 04 Dec 1998 | 27 Years 11 Months | Current |
| Darshan Harish Bhawsar Also directs: Garonit Pharmaceuticals Private Limited, Neelam Garg Foundation | Director | 05 Mar 2025 | 1 Years 8 Months | Current |
Peer comparison
R.N. Laboratories Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atul Bioscience Limited | ₹136.8 Cr (FY 2025) | 3.0% | Atul, Gujarat, India | |||
| Lasa Laboratory Private Limited | ₹136.67 Cr (FY 2016) | 92.0% | Badlapur, Maharashtra, India | |||
| Corvine Chemicals and Pharmaceuticals Private Limited | ₹136.26 Cr (FY 2025) | 10.0% | Bidar, Karnataka, India | |||
| Kinvan Private Limited | ₹135.98 Cr (FY 2025) | 11959.0% | Solan, Himachal Pradesh, India | |||
| R.N. Laboratories Private Limitedthis company | ₹135.13 Cr (FY 2025) | ₹49.33 Lakh | 0.4% | 19.0% | Mumbai, Maharashtra, India | |
| Alkaloids Pvt Ltd. | ₹134.62 Cr (FY 2024) | 42.0% | Hyderabad, Telangana, India | |||
| Cytobiologics Private Limited | ₹134.03 Cr (FY 2024) | 347.0% | Patancheru, Telangana, India | |||
| Maithri Drugs Private Limited | ₹131.9 Cr (FY 2024) | 14.0% | Hyderabad, Telangana, India | |||
| B E C Chemicals Private Limited | ₹130.65 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of R.N. Laboratories Private Limited, buy the company report.
Auditor
R.N. Laboratories Private Limited is audited by R A KUVADIA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R A KUVADIA & CO | FY 2023 | 105487W |
Shareholding
The shareholding of R.N. Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of R.N. Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jun 2023 | 100812532 | Hdfc Bank Limited | ₹25 Cr | Open | |
| 05 Jan 2023 | 100669255 | Hdfc Bank Limited | ₹25 Cr | Open | |
| 03 Aug 2019 | 100290495 | Citi Bank N.A. | ₹60 Cr | Open | |
| 28 Aug 2017 | 100136513 | Citi Bank N.A. | ₹2 Cr | Open | |
| 30 Dec 2014 | 10568036 | Citi Bank N.A. | ₹40 Cr | Open |
To see the full charge records of R.N. Laboratories Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
R.N. Laboratories Private Limited has 1 deal on record (1 secondary share transfer); the latest was in October 2018.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
R.N. Laboratories Private Limited has 29 court cases on record: 20 filed by R.N. Laboratories, 9 filed against it. 4 cases are pending and 25 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 3 | 2 |
| District courts | 13 | 5 | 2 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 29)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by M/S Nisa Industrial Services Pvt Ltd., | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrent Cases SW) | Filed by the company against LCL Logistix India Pvt Ltd and Ors | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by M/S Nisa Industrial Services Pvt Ltd., | Disposed |
| High Court, MAHARASHTRA | Court case (COMSS) | Filed by the company against Epitome Residency Pvt. Ltd. | Disposed |
| High Court, MAHARASHTRA | Court case (COMEX) | Filed by the company against Epitome Residency Pvt. Ltd. | Disposed |
To see the full case history of R.N. Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for R.N. Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
R.N. Laboratories has 6 GST registrations: 4 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECS2969P2ZI | Maharashtra | Active | 19 Aug 2017 |
| 27AAECS2969P3ZH | Maharashtra | Active | 19 Dec 2020 |
| 24AAECS2969P1ZP | Gujarat | Active | 01 Jul 2017 |
| 24AAECS2969P2ZO | Gujarat | Active | 21 Sep 2017 |
To see the full GST registrations and return filing status of R.N. Laboratories Private Limited, buy the company report.
Recent activity
R.N. Laboratories Private Limited has 11 board changes on record since 1998: 5 appointments and 6 cessations. The latest: Darshan Harish Bhawsar ceased to be Additional Director on 29 Sep 2025.
20 earlier events are in the company report.
Frequently asked questions
R.N. Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 04 December 1998 (28+ years old) and is registered under CIN U24200MH1998PTC117339.
R.N. Laboratories has 5 current directors:
- Vijay Nilkanth Koyande - Director
- Rohit Shamlal Garg - Director
- Sanket Dhondiraj Sawant - Director
- Nitin Sham Lal Garg - Director
- Darshan Harish Bhawsar - Director
The latest financial statements of R.N. Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of R.N. Laboratories is 27AAECS2969P2ZI, registered in Maharashtra. The company has 6 GST registrations in all, of which 4 are active and 2 are cancelled or inactive. Other active GSTINs include 27AAECS2969P3ZH (Maharashtra), 24AAECS2969P1ZP (Gujarat), 24AAECS2969P2ZO (Gujarat).
The CIN (Corporate Identification Number) of R.N. Laboratories is U24200MH1998PTC117339. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
R.N. Laboratories has 29 court cases on record: 20 filed by the company and 9 filed against it. 4 are pending. Most are in the high courts.
R.N. Laboratories was incorporated on 04 December 1998, making it 28+ years old. It is registered with the Registrar of Companies, Mumbai.
R.N. Laboratories has 1 deal on record (1 secondary share transfer); the latest was in October 2018.
The peers of R.N. Laboratories by revenue are Atul Bioscience Limited, Lasa Laboratory Private Limited, Corvine Chemicals and Pharmaceuticals Private Limited, Kinvan Private Limited, Alkaloids Pvt Ltd. and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Darshan Harish Bhawsar ceased to be Additional Director on 29 Sep 2025. Vijay Nilkanth Koyande ceased to be Additional Director on 29 Sep 2025. Vijay Nilkanth Koyande was appointed as Director on 13 Aug 2025. R.N. Laboratories has 11 board changes on record in total.
Yes, R.N. Laboratories is registered as an MSME under Udyam registration (number: UDYAM-GJ-22-0027771).

